Research

Study outlines ‘perfect storm’ that led to Colombia’s antibiotic resistance epidemic


Cesar-Arias
By Hannah Rhodes | November 9, 2017

The nearly simultaneous emergence of a gene responsible for producing carbapenemases – enzymes that kill the most powerful antibiotics used against life-threatening, multidrug-resistant bacterial infections – coupled with the introduction of a bacterial clone that spread between patients created the “perfect storm” that led to today’s antibiotic resistance epidemic in Colombia. Results of this study, led by investigators from The University of Texas Health Science Center at Houston (UTHealth), Universidad El Bosque and Case Western Reserve University, have been published in the Journal of Infectious Diseases.

Senior author Cesar Arias, M.D., Ph.D., professor and director of the Center for Antimicrobial Resistance and Microbial Genomics at McGovern Medical School at UTHealth, and his fellow researchers found that the epidemic began with what he described as a “promiscuous” carbapenemase gene that spread horizontally across a particular type of Gram-negative bacteria. The gene produced an enzyme that broke down powerful carbapenems, the “last-resort” reliable antibiotic drugs used to treat Gram-negative bacteria. The origin of the gene is still unknown, but it spread rapidly from patient to patient throughout the country.

Researchers sequenced the genomes of 133 samples of Klebsiella pneumoniae, a bacterium that can cause serious illness including bloodstream infections, wound infections, pneumonia and meningitis. The samples, recovered from 24 hospitals across Colombia, were collected between 2002 and 2014, before and after the emergence of carbapenem resistance in these organisms. Colombia has a high density of antibiotic-resistant organisms compared to other countries and like many others, is struggling to combat an epidemic.

To exacerbate the crisis, shortly after the spread of the gene, a bacterial clone carrying a similar antibiotic-killing gene was introduced into the country, most likely via an infected patient who traveled from the U.S., where the clone was already present. This bacterial lineage carried multiple antibiotic resistance determinants and quickly spread through person-to-person contact, as happened before in other countries.

“With the availability of these data, we could pinpoint the major drivers of the epidemic: when the first strain was identified, how it was disseminated and how it reached this level of epidemic,” said Arias, who is also director of the Center for Infectious Diseases at UTHealth School of Public Health.

The approach used in this paper could help Colombia and other countries working to combat antibiotic resistance.

“If you have a bacteria passing from one patient to another, you can enact very strict infection control measures to stop an epidemic,” said Arias. “But how do you stop a gene passing from bacteria to bacteria if you can’t see it? The dissemination of the gene was fueled by the overuse of antibiotics because it could not easily be treated.”

According to Arias, this approach could potentially help researchers and health care providers target specific clinical settings where the gene is being disseminated versus where the clone is and enact either infection control or antibiotic stewardship measures.

“By tracking the molecular epidemiology of an epidemic like this, Laura Rojas and the team uncovered important lessons that will help us combat other resistant bacteria,” said Robert A. Bonomo, M.D., coauthor on the paper and professor of medicine at the Cleveland VA Medical Center and Case Western Reserve University School of Medicine. Laura Rojas was first author on the paper and is a graduate student at Case Western Reserve University School of Medicine.

Researchers from Case Western Reserve University; Louis Stokes Cleveland VA Medical Center; Jackson Laboratory for Genomic Medicine; International Center for Medical Research and Training in Cali, Colombia; International Center for Microbial Genomics Universidad El Bosque in Bogotá, Colombia; American Museum of Natural History; University of Pennsylvania and Children’s Hospital of Philadelphia were coauthors on the paper.

The research was funded by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases grants K24-AI114818, R01-AI093749, R21-AI114961 and R21/R33-AI121519 (awarded to Arias) and grants R21AI114508, R01AI100560, R01AI063517 and R01AI072219 (awarded to Bonomo). Funds and facilities from the Cleveland Department of Veterans Affairs, VISN 10 Geriatric Research Education and Clinical Center and the Veterans Affairs Office Research and Development (1I01BX001974 to Bonomo) also supported the work.

Tags |



Social Posts

profile_image

Veterans Affairs

@DeptVetAffairs

How does a #Navy submariner from #Hollis #Queens #NYC become a #farmer in #NC?Check out the latest #BorneTheBattle to find out!iTunes: https://t.co/CCghj5FYUI Stitcher: https://t.co/rsLwa9Zmyr Blog: https://t.co/DeMB5MJ1cw https://t.co/sXnlH1Evh1

13 mins ago
profile_image

U.S. Department of Veterans Affairs

VeteransAffairs

“Veterans might be eligible for things they had no idea they were eligible for, no matter what age,” says Kim, an Army National Guard Veteran. She urges Veterans to take advantage of their VA benefits.#ExploreVA health care: http://bit.ly/2YiwKI6#WomensHistoryMonth

13 mins ago
profile_image

Veterans Affairs

@DeptVetAffairs

“Veterans might be eligible for things they had no idea they were eligible for, no matter what age,” says Kim, an Army National Guard Veteran. She urges Veterans to take advantage of their VA benefits.#ExploreVA health care: https://t.co/0NWKCkAgpl#WomensHistoryMonth

2 hours ago
profile_image

Texas Children's

@TexasChildrens

Sintoniza y escucha Liberman Media Radiotón en EL NORTE 107.9FM, LA RAZA 103.3FM o 98.5FM y La Ranchera 850AM o 101.7FM el 28 y 29 de marzo. Obtén más información: https://t.co/oc0IpWZQ7e https://t.co/Iylq9eQw6V

9 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Veterans talking Veterans back from the brink: A new approach to policing and lives in crisis https://t.co/uVpsxq1Pgs via @washingtonpost

10 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

How we’re helping #AYAcancer patients and survivors navigate life with #cancer: https://t.co/4xILlEE9VU @mroth_MD @jalivingston_md #endcancer

11 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

In cohort of #melanoma and #kidneycancer patients, study led by @JenWargoMD found B cells may be effective in predicting which #cancer patients will respond to #immunotherapy: https://t.co/5yQlDjKwCX #CancerMoonshot #AACR19 #endcancer

11 hours ago
profile_image

Memorial Hermann

@memorialhermann

After delaying her colonoscopy, 66-year-old Brenda’s screening revealed shocking news—she had cancer. Read her story: https://t.co/EVuApzmgPK

11 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

@MrsDeniseannco3 @MelanomaReAlli @washingtonpost @NobelPrize We'll be thinking of your husband.

12 hours ago
profile_image

MD Anderson Cancer Center

MDAnderson

“We’re working on ways to improve the function of the blood vessels so we can get chemotherapy to the places that need it most – the tumors,” says Dr. Keri Schadler, whose research is exploring how exercise can help get chemotherapy into solid tumors more efficiently, leading our patients toward better outcomes. #endcancer

12 hours ago
profile_image

Rice University

@RiceUniversity

RT @BakerInstitute: Starting Now: Anita Hill takes the stage to talk about how to stop sexual harassment in the workplace. #MeTooWatch th…

13 hours ago
profile_image

Rice University

@RiceUniversity

RT @RiceUNews: "I suspect that many of you have the idea that things are so entrenched that we can’t make change," Anita Hill tells the cro…

13 hours ago
profile_image

Memorial Hermann

MemorialHermann

After delaying her colonoscopy, 66-year-old Brenda’s screening revealed shocking news—she had cancer. Read her story: http://spr.ly/6187EZ2YN

13 hours ago
profile_image

BCMHouston

@bcmhouston

Our investigators conduct hundreds of studies, ranging from small, short-term studies to large trials with thousands of patients across many institutions. See our current clinical trials: https://t.co/3ulBSYdEhZ #clinicaltrials #research https://t.co/Sf6yBq7Dmm

13 hours ago
profile_image

Baylor College of Medicine

BaylorCollegeOfMedicine

Have you voted in STAT Madness yet? Our research on a common antibiotic that has been shown to damage the heart is looking to make it into the Final 4. #STATMadness

13 hours ago